Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,158.0
-4.5 (-0.14%)

 

  • STI Straits Times Index
    3,158.0
    -4.5 (-0.14%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,575.2
    -4.7 (-0.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,842.1
    103.2 (0.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,589.7
    -21.1 (-0.58%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,948.7
    -9.8 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,095.5
    -12.0 (-0.20%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,814.5M
  • Value: 1,155.6M
  • Rise: 178
  • Fall: 156
  • Unch: 429

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MM2 Asia0.074+0.002
MarcoPolo Marine0.026+0.002
CFM0.345+0.035
Hanwell0.455+0.030
RH PetroGas0.124+0.031
Kim Heng0.078+0.011
New Wave0.013+0.002
Singtel2.320-0.010
OEL0.016+0.001
CPH0.007+0.002

World Indices

World Indices
Name Last Change
Nasdaq 14,069.4 +49.1
HSI 28,842.1 +103.2
HSCEI 10,751.0 +34.7
Jakarta 6,095.5 -12.0
Nikkei 225 28,948.7 -9.8
SSE Comp 3,589.7 -21.1
Shanghai A 3,762.7 -22.1
Shanghai B 256.6 -0.9
KOSPI 3,249.3 +24.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VOLITIONRX LIMITED VOLITIONRX LIMITED
Updated on 11 Jun 2021 (End of trading day)
Last (USD): 3.550 Change: -0.030 High: 3.569 Remarks: -
Change (%): -0.84 Low: 3.500
Open 3.530 Yesterday's Close 3.5799999999999996
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 82,741 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.76745 Trailing EPS (USD) e -0.77750 NAV (USD) b 1.1772
PE a - Trailing PE f - Price / NAV b 3.0156
Dividend (USD) d - Cash In Hand (USD) g 1.2467 Issued & Paid-up Shares c 52,892,700
Dividend Yield (%) d - Price / Cash In Hand g 2.848 Treasury Shares h -
Market Cap (M) 94.142 Enterprise Value (M) 65.186
Piotroski F Score 1 Exchange Code VNRX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 60.39 Free Float (%) 65.4
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VOLITIONRX LIMITED NYSE American 94.142 - - 3.0156 -
Industry Medical Specialties NYSE American 239.581 - 162.081 6.7583 -
Local Peer INFUSYSTEM HOLDINGS INC NYSE American 916.157 52.860 49.761 21.3309 -
Local Peer STEREOTAXIS INC NYSE American 618.852 - - 17.8000 -
Local Peer RETRACTABLE TECHNOLOGIES INC NYSE American 379.359 14.248 8.549 5.6133 -
Local Peer ALPHA PRO TECH NYSE American 124.322 4.590 4.882 2.0123 -
Local Peer ELECTROMED INC NYSE American 89.378 21.478 27.324 2.7189 -
Local Peer MILESTONE SCIENTIFIC INC NYSE American 71.918 - - 3.7567 -
Local Peer DAXOR CORP NYSE American 50.102 - - 3.1963 -
Local Peer XTANT MEDICAL HLDGS INC NYSE American 32.206 - - 0.9652 -
Local Peer RA MEDICAL SYSTEMS INC NYSE American 19.375 - - 1.2793 -
Global Peer ABBOTT LABORATORIES NYSE 195,290.286 43.660 34.286 5.8188 1.388
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 182,816.974 28.677 23.071 5.2147 0.191
Global Peer DANAHER CORP NYSE 176,194.179 50.198 50.198 4.7427 0.291
Global Peer MEDTRONIC PLC NYSE 166,533.612 46.182 46.182 3.2382 1.874
Global Peer INTUITIVE SURGICAL INC NASDAQ 102,340.804 96.493 87.217 10.0794 -
Global Peer STRYKER CORP NYSE 96,368.371 60.268 68.443 7.1373 0.919
Global Peer BECTON DICKINSON & CO NYSE 70,564.322 92.000 43.027 2.8426 1.315
Global Peer EDWARDS LIFESCIENCES CORP NYSE 62,157.484 75.489 73.041 13.3430 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 60,971.248 - 426.372 3.8788 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 51,833.043 38.306 38.305 3.5689 1.804
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), NOVOCURE LTD (NASDAQ), WATERS CORP (NYSE), STERIS PLC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), HOLOGIC INC (NASDAQ), MICROPORT (HKEx), DENTSPLY SIRONA INC (NASDAQ), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), COCHLEAR LTD (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), WEIGAO GROUP (HKEx), Top Glove (SGX), TOPGLOV (Bursa), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), SOTERA HEALTH CO (NASDAQ), HARTA (Bursa), STAAR SURGICAL CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NEVRO CORP (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), CARDIOFLOW-B (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEOGEN CORP (NASDAQ), QUIDEL CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), INMODE LTD (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), PEIJIA-B (HKEx), AXONICS INC (NASDAQ), LIFETECH SCI (HKEx), VERICEL CORP (NASDAQ), SUPERMX (Bursa), BUTTERFLY NETWORK INC (NYSE), OUTSET MEDICAL INC (NASDAQ), HESKA CORP (NASDAQ), KANGJI MEDICAL (HKEx), AVANOS MEDICAL INC (NYSE), TREACE MED CONCEPTS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AK MEDICAL (HKEx), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PULMONX CORPORATION (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), EARGO INC (NASDAQ), INOGEN INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANOSONICS LIMITED (ASX), CIRC (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), CHUNLI MEDICAL (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), DERMTECH INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CRYOLIFE INC (NYSE), ATRION CORP (NASDAQ), MODERN DENTAL (HKEx), 908 DEVICES INC (NASDAQ), BIOVENTUS INC (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), KDL MEDICAL (HKEx), AXOGEN INC (NASDAQ), BASECARE-B (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), SURMODICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), NEUROPACE INC (NASDAQ), VAPOTHERM INC (NYSE), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), ONCOCYTE CORP (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), QUOTIENT LTD (NASDAQ), SIENTRA INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEURONETICS INC (NASDAQ), MISONIX INC (NASDAQ), Medtecs Intl (SGX), PROFOUND MED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), IRADIMED CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), YESTAR HEALTH (HKEx), NEMAURA MEDICAL INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), CORMEDIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), INVACARE CORP (NYSE), UGHealthcare (SGX), MEDICAL DEVELOPMENT INTL (ASX), AROA BIOSURGERY LTD (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), LUCIRA HEALTH INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), INTRICOM CORP (NASDAQ), TITAN MEDICAL INC (NASDAQ), CYCLOPHARM LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CONFORMIS INC (NASDAQ), TELA BIO INC (NASDAQ), PW MEDTECH (HKEx), VINCENT MED (HKEx), MYMD PHARMACEUTICALS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), OPTISCAN IMAGING (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), CELSION CORPORATION (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), IMPEDIMED LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), BIOLASE INC (NASDAQ), FONAR CORP (NASDAQ), IRIDEX CORP (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LENSAR INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), SOLENO THERAPEUTICS INC (NASDAQ), NEPHROS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), APPLIED UV INC (NASDAQ), SDI LTD (ASX), ELECTROCORE INC (NASDAQ), IMMUCELL CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NEOVASC INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), CARDIEX LTD (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), RESONANCE HEALTH LTD (ASX), RGTBHD (Bursa), PLUS THERAPEUTICS INC (NASDAQ), Biolidics (SGX), YUNNAN ENERGY (HKEx), ADVENTA (Bursa), HANCOCK JAFFE LABORATORIES INC (NASDAQ), COMPUMEDICS (ASX), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), INSPIREMD INC (NASDAQ), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), LKL (Bursa), SINTX TECHNOLOGIES INC (NASDAQ), DIMERIX LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), ADHERIUM LIMITED (ASX), OBALON THERAPEUTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), Yunnan Energy (SGX), TENAX THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), NUWELLIS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIFE HEALTHCARE (HKEx), DYNATRONICS CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), OVENTUS MEDICAL LTD (ASX), CYANOTECH CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), METALICITY LIMITED (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), NEUROMETRIX INC (NASDAQ), DORSAVI LTD (ASX), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.170
+5.03 %
10 Days -+0.060
+1.72 %
20 Days -+0.140
+4.11 %
Medium Term Return 3 Months --0.460
-11.47 %
6 Months -+0.010
+0.28 %
1 Year -+0.650
+22.41 %
Long Term Return 2 Years -+0.530
+17.55 %
3 Years -+1.150
+47.92 %
Annualised Return Annualised --
+13.94 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.820 - 6.670 Change From 1 Year Low +0.730 % Change From 1 Year Low (%) +25.89
Change From 1 Year High -3.120 % Change From 1 Year High (%) -46.78
2 Years Range 2.220 - 6.840 Change From 2 Years Low +1.330 % Change From 2 Years Low (%) +59.91
Change From 2 Years High -3.290 % Change From 2 Years High (%) -48.10
5 Years Range 1.440 - 6.840 Change From 5 Years Low +2.110 % Change From 5 Years Low (%) +146.53
Change From 5 Years High -3.290 % Change From 5 Years High (%) -48.10
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Jun 2021 3.530 3.569 3.500 3.550 82,741 -
10 Jun 2021 3.600 3.610 3.470 3.580 101,885 -
09 Jun 2021 3.600 3.620 3.570 3.600 84,312 -
08 Jun 2021 3.590 3.640 3.550 3.620 122,963 -
07 Jun 2021 3.400 3.560 3.370 3.560 205,547 -
04 Jun 2021 3.520 3.556 3.370 3.380 132,627 -
03 Jun 2021 3.560 3.560 3.485 3.550 102,118 -
02 Jun 2021 3.500 3.570 3.460 3.560 185,625 -
01 Jun 2021 3.500 3.510 3.450 3.510 123,570 -
28 May 2021 3.650 3.670 3.480 3.490 125,531 -
27 May 2021 3.650 3.670 3.560 3.630 112,546 -
26 May 2021 3.530 3.680 3.520 3.620 124,451 -
25 May 2021 3.530 3.640 3.450 3.520 145,997 -
24 May 2021 3.500 3.610 3.420 3.530 187,231 -
21 May 2021 3.540 3.640 3.470 3.480 155,076 -
20 May 2021 3.600 3.700 3.500 3.500 142,335 -
19 May 2021 3.620 3.760 3.450 3.560 189,511 -
18 May 2021 3.460 3.968 3.420 3.690 932,498 -
17 May 2021 3.420 3.510 3.380 3.490 183,885 -
14 May 2021 3.050 3.440 3.010 3.410 227,013 -
13 May 2021 3.170 3.230 2.960 3.010 247,874 -
12 May 2021 3.140 3.280 3.140 3.160 212,998 -
Summary
Current 2 Weeks
(28 May 2021 to 11 Jun 2021)
3.650 3.670 3.370 3.550 1,266,919 -
Previous 2 Weeks
(14 May 2021 to 27 May 2021)
3.050 3.670 3.010 3.630 2,400,543 -
4 Weeks from
(16 Apr 2021 to 13 May 2021)
3.290 3.670 3.120 3.010 3,805,536 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.